Kawasaki, Japan

Kentaro Inagawa

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kentaro Inagawa. Retrieved from https://idiyas.com/inventor/kentaro-inagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kentaro Inagawa: Innovator in Food Science

Introduction

Kentaro Inagawa is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of food science, particularly through his innovative patent related to glycine.

Latest Patents

Inagawa holds a patent titled "Food containing glycine and use thereof." This invention provides a food product that contains glycine or a substance that can be hydrolyzed to yield glycine, with a minimum of 0.5 g per serving. The applications of this food include its use as a flavoring agent, a remedy for deep sleep disorders, and a means to improve bowel movements.

Career Highlights

Kentaro Inagawa is associated with Ajinomoto Co., Ltd., a leading company in the food industry. His work focuses on enhancing food products through scientific innovation, contributing to better health and wellness.

Collaborations

Inagawa collaborates with talented individuals such as Chika Morishima and Shinobu Seki, who share his passion for advancing food technology.

Conclusion

Kentaro Inagawa's work exemplifies the intersection of food science and innovation, showcasing how a single patent can have diverse applications in improving health and nutrition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…